Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

4713 Journals
3558 Congresses
8200+ Unique Records

Journal for ImmunoTherapy of Cancer


Title Abbreviation
J Immunother Cancer
Electronic ISSN
2051-1426
Readership
Clinical Pharmacologists, Clinicians, Immunologists, Oncologists, Pharmacologists, Physicians, Physicians - Medicine
Scope
The Journal for ImmunoTherapy of Cancer (JITC) is the open access, peer reviewed, online journal of the Society for Immunotherapy of Cancer (SITC). The journal publishes articles on all aspects of tumor immunology and cancer immunotherapy and, in doing so, aims to enrich communication and advance scientific understanding among the many stakeholders in this rapidly evolving field. Topics of interest range widely across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.
Sponsoring Association(s)
Society for Immunotherapy of Cancer (SITC)
Publisher Name
BMJ Publishing Group
To see more details about Journal for ImmunoTherapy of Cancer, Subscribe Now!
Impact Factor JCR Categories/Rank Submission to Acceptance Acceptance to Online Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
 
– Kait G
Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
– Michael K.
Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
- Weill Cornell Medical Library